Portolan Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-146,168
Closed -$3.57M 176
2020
Q3
$3.57M Sell
146,168
-18,641
-11% -$435K 0.4% 91
2020
Q2
$3.91M Sell
164,809
-87,550
-35% -$2.03M 0.45% 84
2020
Q1
$4.35M Sell
252,359
-52,682
-17% -$964K 0.65% 52
2019
Q4
$5.38M Sell
305,041
-149,403
-33% -$2.53M 0.54% 63
2019
Q3
$8.04M Sell
454,444
-86,146
-16% -$1.74M 0.91% 38
2019
Q2
$11.6M Buy
+540,590
New +$11.3M 1.24% 30

Other funds holding EXEL

Portolan Capital Management's EXEL Position: Q4 2020 in Review

Portolan Capital Management sold out of Exelixis (EXEL) in Q4 2020, closing a stake of 146,168 shares — an estimated $3.57M sold.

Portolan Capital Management first reported a position in EXEL in Q2 2019 and held it in 6 quarters. The position peaked at $11.6M in Q2 2019. 351 funds tracked by Wall St. Rank hold EXEL as of Q4 2020.

  • Portolan Capital Management reported no remaining Exelixis position as of Q4 2020 after selling out during the quarter.
  • Portolan Capital Management sold 146,168 Exelixis shares in Q4 2020, an estimated $3.57M.
  • Portolan Capital Management first reported a position in Exelixis in Q2 2019 and held it in 6 quarters.
  • Portolan Capital Management's Exelixis position peaked at $11.6M in Q2 2019.
  • 351 funds tracked by Wall St. Rank held Exelixis as of Q4 2020.

Based on Portolan Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.